1. Home
  2. CBAT vs OKYO Comparison

CBAT vs OKYO Comparison

Compare CBAT & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CBAK Energy Technology Inc.

CBAT

CBAK Energy Technology Inc.

N/A

Current Price

$0.82

Market Cap

70.9M

Sector

Miscellaneous

ML Signal

N/A

Logo OKYO Pharma Limited

OKYO

OKYO Pharma Limited

N/A

Current Price

$1.54

Market Cap

81.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CBAT
OKYO
Founded
1999
2007
Country
China
United Kingdom
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
70.9M
81.3M
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
CBAT
OKYO
Price
$0.82
$1.54
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$6.33
AVG Volume (30 Days)
263.8K
80.7K
Earning Date
05-18-2026
07-18-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$195,189,306.00
N/A
Revenue This Year
$66.88
N/A
Revenue Next Year
$41.54
N/A
P/E Ratio
N/A
N/A
Revenue Growth
10.52
N/A
52 Week Low
$0.46
$1.34
52 Week High
$1.24
$3.20

Technical Indicators

Market Signals
Indicator
CBAT
OKYO
Relative Strength Index (RSI) 72.23 49.44
Support Level $0.77 $1.45
Resistance Level $0.89 $1.73
Average True Range (ATR) 0.08 0.08
MACD 0.02 -0.00
Stochastic Oscillator 75.46 28.64

Price Performance

Historical Comparison
CBAT
OKYO

About CBAT CBAK Energy Technology Inc.

CBAK Energy Technology Inc is engaged in the manufacture, commercialization, and distribution of a variety of standard and customized lithium and sodium high-power rechargeable batteries. The batteries are used in light vehicles, electric vehicles, energy storage devices, and other high-power applications. The company has two operating segments; CBAK, which derives maximum revenue, and includes the manufacturing, commercialization, and distribution of various standard and customized lithium-ion rechargeable batteries; and the Hitrans segment, which includes the development and manufacturing of NCM precursor and cathode materials. Geographically, the company derives its key revenue from Mainland China, followed by Europe, India, Africa, and other regions.

About OKYO OKYO Pharma Limited

OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.

Share on Social Networks: